Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aardvark, ABVC, Actinium, Celldex, Ideaya, Intellia, Kymera, Mustang, Ocular, Oxurion, Pharvaris, Skye,  Sumitomo, Vaccitech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acadia, ADC, Astellas, Beigene, Crispr, Disc, Editas, Faron, Genmab, Gritstone, Immunogen, Keros, Nuvox, Roche, Ryvu, Servier, Vertex, Vor, Wugen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annovis, Arvinas, Azafaros, Cingulate, Lianbio, Repare, Ultimovacs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baudax, Bioinvent, Bridgebio, Coya, Durect, Emergex, Fibrogen, Fluoguide, Lixte, Ocular, Oncternal, Replimune, Rigel, Ventyx, Vera, Vistagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Airway, Allovir, Anavex, Bpgbio, Cali, Defender, Galapagos, Glaukos, Harmony, Mereo, Okyo, Orsobio, Repare, Sareum, Tiziana, Ultragenyx, Vaxart, Vaxxas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Amolyt, Astrazeneca, Bellerophon, Endo, Enterin, Fogpharma, Harbour, IGM, Immuneering, Newamsterdam, Ractigen, Sirnaomics, Synlogic, Tonix, Vaxess, Vivavision, Walden.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Athersys, Aurinia, Biontech, Bluejay, Connect, Eli Lilly, LoMedivir, Neurotrauma, Novartis, Oncoc4, Pfizer, Realta, Scisparc, Skye.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Artax, Aviceda, Brii, Clarametyx, Clearside, Hookipa, Ionis, Monopar, Sensei.

Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Abbvie, Abcuro, Adiso, Amgen, Aquestive, Ascendis, Caliway, Canbridge, Celldex, Coave, Glyscend, Horizon, Kahr, Nacuity, Onconano, Pathalys, Precision, Rayzebio, Sanofi, Selecta, Snipr, Travere, Xencor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: A2, Abbisko, Algiax, Alterity, Alzecure, Aum, Consynance, Debiopharm, Dermbiont, Fore, Genprex, Hansa, Harbour, Immorna, Luzhu, Pfizer, Pyxis, Revive, Selection, Springworks, Theratechnologies.